AzTrials
AzTrials

Zone 2 Flexor Tendon Lacerations of the HandPhase 2NCT01344980

The Effects of a Stainless Steel Suture MGH Flexor Tendon Repair Coupled With Early Aggressive Range of Motion Rehabilitation: a Randomized Controlled Trial

A Phase 2 study testing Stainless steel suture, Polypropylene suture and Aggressive early active range of motion rehabilitation in people with Zone 2 Flexor Tendon Lacerations of the Hand, run by University of Manitoba at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators are comparing the combination of a stainless steel repair and aggressive early active range of motion rehabilitation protocol for flexor tendon lacerations in the hand with a current, accepted treatment offered at our institution. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
What is being tested?
Stainless steel suture, Polypropylene suture and Aggressive early active range of motion rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteCanada
Study dates
Jun 2011to Jun 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • adults
  • living in Winnipeg, Manitoba
  • zone II flexor tendon lacerations in a single finger
  • able to consent to and comply with surgery

Who cannot join

  • crush injuries
  • vascular injuries requiring re-vascularization
  • fractures
  • infection
  • prior hand injury requiring surgery

Trial locations and contacts

1 site in 1 country.

Leif J Sigurdson, MD contact

204-787-7374

lsigurdson2@exchange.hsc.mb.ca

Ian R MacArthur, MD contact

204-990-6397

i_macarthur@shaw.ca

Canada1 site
  • Health Sciences Center

    Winnipeg, Manitoba, R3A 1R9

    Leif J Sigurdson, MD, 204-787-7374, Leif Sigurdson <lsigurdson2@exchange.hsc.mb.ca>

    Ian R MacArthur, MD

Other trials in Canada

About this study

Official title: A Pilot Study of a Randomized Controlled Trial Comparing Stainless Steel Suture Repair Coupled With Aggressive Post-Operative Rehabilitation to Polypropylene Suture Paired With Active Range of Motion Rehabilitation

The investigators are comparing the combination of a stainless steel repair and aggressive early active range of motion rehabilitation protocol for flexor tendon lacerations in the hand with a current, accepted treatment offered at our institution. Outcomes to be assessed will be time to return to work, joint range of motion in the injured fingers, and any potential complications that may arise (ex: surgical infections or repair rupture). All proposed treatments included in this study are currently being offered at our institution, but not in a randomized fashion.

Read the detailed description

This study will serve as a pilot-study for a future randomized controlled trial. Adult patients with zone 2 flexor tendon lacerations of the hand (anatomically from the A1 pulley of the hand to the insertion of the flexor digitorum superficialis) who have presented to the emergency room acutely (within 1 week of injury) at the Health Sciences Center in Winnipeg will be asked for their participation in this study. Consent will be obtained by a plastic surgery resident either in the emergency room or in the plastic surgency emergency decanting clinic. The investigators will include twenty-four patients in the study, randomized into one of two treatment groups (groups A and B) by block randomization. Randomization will be done once patients agree to participate in the study. All patients will be booked for surgery on the emergency slate. Each treatment group will be treated by a single surgeon who is an expert at treatment of these injuries. Group A patients will have their laceration(s) repaired using a modified Becker repair technique using stainless steel suture in the operating room, and then will proceed to undergo an aggressive early active range of motion rehabilitation administered by the hand therapists at HSC. Group B patients will undergo a double-locking loop suture repair using polypropylene. They will then undergo a less aggressive active range of motion rehabilitation protocol which is currently offered to patients at our center. Follow-up will occur in plastic surgery outpatient clinic at post-operative weeks 1, 2, 4, 6 and 12. Follow-up with hand therapy will be at the discretion of the therapists. At each visit with hand therapy, joint range of motion will be assessed at the PIP and DIP joints in the affected fingers. Final range of motion will be assessed using the Strickland system for evaluating flexor tendon surgery outcomes, and will be done by a blinded hand therapist.

Being tested
Stainless steel suture, Polypropylene suture, Aggressive early active range of motion rehabilitation, Early active range of motion rehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stainless steel sutureProcedure or surgery

    Stainless steel suture material will be used (size 3-0) in an MGH repair technique

  • Polypropylene sutureProcedure or surgery

    Polypropylene suture (size 3-0) will be used in a double-locking loop repair technique

  • Aggressive early active range of motion rehabilitationBehavioural

    Patients undergoing this form of rehabilitation will have their splints discontinued at 4 weeks and ideally will be back at work at normal duties by 6 weeks. This rehabilitation uses more movement at a faster progression than other early active range of motion protocols.

  • Early active range of motion rehabilitationBehavioural

    Patients undergoing this form of rehabilitation will have their splints discontinued at 6 weeks and ideally will be back at work at normal duties by 10-12 weeks. This rehabilitation uses less movement at a slower progression than the early AROM rehabilitation protocol specified in the experimental group

Study groups in NCT01344980
Study groupRoleWhat they receive
Stainless steel MGHExperimentalPatients in this study arm will have their flexor tendon laceration repaired using stainless steel suture (size 3-0) in an MGH repair technique. They will then undergo aggressive early active range of motion rehabilitation post-operatively.
Receives: Procedure: Stainless steel suture; Behavioral: Aggressive early active range of motion rehabilitation
Polypropylene DOLLActive comparatorPatients in this study arm will have their flexor tendon laceration repaired using polypropylene suture (size 3-0) in a double-locking loop repair technique. They will then undergo aggressive early active range of motion rehabilitation post-operatively.
Receives: Procedure: Polypropylene suture; Behavioral: Early active range of motion rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return to work

    At each clinic visit at the above mentioned time periods, the clinician will ask the patient if they have returned to work (if applicable)

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  2. Finger joint range of motion (PIP, DIP, MCP)

    At each clinic / occupational therapy visit, a blinded assessor will determine the total range of motion of the finger DIP, PIP and MCP joints

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

Secondary outcomes (8)
  1. Compliance with therapy

    At each clinic and occupational therapy visit, an assessor will ask the patient if they have been compliant with therapy

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  2. Rupture

    At each follow-up visit with the clinician or occupational therapist, the presence of a rupture will be assessed for clinically. Alternatively this will be recorded if the patient presents to the emergency room with a flexor tendon rupture

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  3. Infection

    At each clinic visit, the patient will be assessed clinically for the presence or absence of an infection. This will also be noted if the patient presents to the emergency room.

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  4. Attendance with follow-up clinic and occupational therapy

    The patient's attendance will be determined at each clinic or occupational therapy visit.

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  5. Use of oral analgesics

    At each clinic visit, the patient will be asked if they are still using oral analgesics

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  6. Oral antibiotic usage

    At each clinic visit, the patient will be asked if they are using oral antibiotics.

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  7. Wound dehiscence (breakdown)

    At each clinic and occupational therapy visit, the patient will be assessed to determine if a wound dehiscence (breakdown) has occurred.

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

  8. Use of occupational therapy adjunctive treatments

    At each occupational therapy visit, it will be recorded that they are either using or not using occupational therapy adjunctive treatments (ex: coban tape, ultrasound or electrical stimulation)

    Measured: Post-operative weeks 1, 2, 4, 6 and 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2011 (estimated)
  2. Study startJun 2011
  3. Primary completionJun 2012 (estimated)
  4. Study completionJun 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01344980
Sponsor's protocol ID
B2010:119
Status last verified
Feb 2011
First submitted
28 Apr 2011
Last updated
29 Apr 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Stainless steel suture, Polypropylene suture and Aggressive early active range of motion rehabilitation in people with Zone 2 Flexor Tendon Lacerations of the Hand, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Apr 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Leif J Sigurdson, MD (204-787-7374, lsigurdson2@exchange.hsc.mb.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return to work (time frame: Post-operative weeks 1, 2, 4, 6 and 12). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in